NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)

Clinical trial NCT06239272 · RECRUITING

Trial details

NCT number: NCT06239272
Sponsor: St. Jude Children's Research Hospital
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Adipocytic Neoplasm Liposarcoma Atypical Fibroxanthoma Angiomatoid Fibrous Histiocytoma Fibrosarcoma NOS Myxofibrosarcoma Angiosarcoma Osteosarcoma, Extraskeletal Dedifferentiated Liposarcoma Myxoid Liposarcoma Pleomorphic Liposarcoma Myxoid Pleomorphic Liposarcoma

Start date: 2024-03-27
Primary completion: 2034-06-01
Enrollment: 139

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.